ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

NCI spends A Third Of Its Budget On Prevention

May 15, 1992

King Tells Centers To Concentrate On Project Grants

October 15, 1976

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986

Society Growth continues, With OS The Largest; ASCO Plans to Reduce flow Of Medical Oncologists; AACR To Impose Page Charges for “Cancer Research:

May 31, 1985

Rauscher, ACS Oppose Kennedy Bill, Defend NCI Special Authority, Say Funding Level Inadequate

May 11, 1979

Professional Societies: AACI Seeks To Define Role Of Cancer Centers In Washington Politics

October 16, 1998